Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis - a mixed treatment comparison of randomized controlled trials
Alimentary Pharmacology and Therapeutics, 08/20/09
Edwards SJ et al. – Esomeprazole 40 mg consistently demonstrates higher healing rates compared with licensed standard– and double–dose PPIs.
Related Articles
Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief
Alimentary Pharmacology and Therapeutics, 10/09/09
Relevance Score: 67%
Efficacy of an Experimental Tin-F-Containing Solution in Erosive Tissue Loss in Enamel and Dentine in situ
Caries Research, 10/28/09
Relevance Score: 66%
Late-onset epithelial ingrowth after laser in situ keratomileusis
Journal of Cataract & Refractive Surgery, 11/13/09
Relevance Score: 64%
Epidemiology of desquamative gingivitis: evaluation of 125 patients and review of the literature
International Journal of Dermatology, 10/01/09
Relevance Score: 64%
The prognostic value of baseline erosions in undifferentiated arthritis
Arthritis Research & Therapy, 10/19/09
Relevance Score: 47%
Today in Esophagus...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA)
Medical Oncology, 12/04/09
Association of C-Reactive Protein Levels and Long-Term Survival after Neoadjuvant Therapy and Esophagectomy for Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/03/09
p53 Genotype Predicts Response to Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus
Annals of Surgical Oncology, 12/02/09
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis
Journal of Pediatric Surgery, 12/04/09
The epidemiology of hospitalization with diarrhea in rural Kenya: the utility of existing health facility data in developing countries
International Journal of Infectious Diseases, 12/04/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer
Expert Review of Anticancer Therapy, 12/04/09
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
Annals of Oncology, 12/04/09
A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors
Annals of Oncology, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


